| Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors PO Pietarinen, CA Eide, P Ayuda-Durán, S Potdar, H Kuusanmäki, ... Oncotarget 8 (14), 22606, 2017 | 19 | 2017 |
| The CDK regulators Cdh1 and Sic1 promote efficient usage of DNA replication origins to prevent chromosomal instability at a chromosome arm P Ayuda-Durán, F Devesa, F Gomes, J Sequeira-Mendes, C Avila-Zarza, ... Nucleic acids research 42 (11), 7057-7068, 2014 | 17 | 2014 |
| Early response evaluation by single cell signaling profiling in acute myeloid leukemia BS Tislevoll, M Hellesøy, OHE Fagerholt, SE Gullaksen, A Srivastava, ... Nature communications 14 (1), 115, 2023 | 16 | 2023 |
| INTERFERON ALPHA AND TYROSINE KINASE INHIBITORS INCREASE TUNNELING NANOTUBES (TNT) FORMATION AND CELL ADHESION IN CHRONIC MYELIOD LEUKEMIA (CML) CELL LINES M Omsland, V Andresen, SE Gullaksen, P Ayuda-Durán, M Popa, ... FASEB journal: official publication of the Federation of American Societies …, 2020 | 15 | 2020 |
| Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies K Melvold, M Giliberto, L Karlsen, P Ayuda‐Durán, R Hanes, T Holien, ... Molecular Oncology 16 (5), 1153-1170, 2022 | 11 | 2022 |
| GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells B Zhang, P Ayuda-Durán, L Piechaczyk, Y Fløisand, MM Safont, ... haematologica 104 (5), e229, 2019 | 8 | 2019 |
| Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening I Grad, R Hanes, P Ayuda-Durán, ML Kuijjer, JM Enserink, ... PLoS ONE, 2021 | 6 | 2021 |
| A cell competition–based small molecule screen identifies a novel compound that induces dual c-Myc depletion and p53 activation DS Tadele, J Robertson, R Crispin, MC Herrera, M Chlubnová, ... Journal of Biological Chemistry 296, 2021 | 6 | 2021 |
| Robust scoring of selective drug responses for patient-tailored therapy selection Y Chen, L He, A Ianevski, P Ayuda-Durán, S Potdar, J Saarela, ... Nature Protocols 19 (1), 60-82, 2024 | 2 | 2024 |
| Standardized assays to monitor drug sensitivity in hematologic cancers P Ayuda-Durán, JU Hermansen, M Giliberto, Y Yin, R Hanes, S Gordon, ... Cell death discovery 9 (1), 435, 2023 | 2 | 2023 |
| screenwerk: a modular tool for the design and analysis of drug combination screens R Hanes, P Ayuda-Durán, L Rønneberg, S Nakken, E Hovig, M Zucknick, ... Bioinformatics 39 (1), btac840, 2023 | 2 | 2023 |
| Clinical forecasting of acute myeloid leukemia using ex vivo drug-sensitivity profiling AN Andersen, AM Brodersen, P Ayuda-Durán, L Piechaczyk, DS Tadele, ... Cell Reports Methods 3 (12), 2023 | 1 | 2023 |
| Clinical Forecasting using Ex Vivo Drug Sensitivity Profiling of Acute Myeloid Leukemia AN Andersen, AM Brodersen, P Ayuda-Durán, L Piechaczyk, DS Tadele, ... bioRxiv, 2022.10. 11.509866, 2022 | 1 | 2022 |
| Promising anti-proliferative indolic benzenesulfonamides alter mechanisms with sulfonamide nitrogen substituents. R Fuentes-Martín, P Ayuda-Durán, R Hanes, L Gallego-Yerga, ... European Journal of Medicinal Chemistry, 116617, 2024 | | 2024 |
| Genome-wide profiling of the hierarchical control of autophagy dynamics using deep learning N Chica, AN Andersen, S Orellana-Munoz, I Garcia, A Nguea P, ... bioRxiv, 2024.04. 06.588104, 2024 | | 2024 |
| metascreen: A modular tool for the design and analysis of drug combination screens R Hanes, P Ayuda-Durán, L Rønneberg, M Zucknick, J Enserink bioRxiv, 2022.07. 10.499451, 2022 | | 2022 |
| Article II. Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B cell malignancies K Melvold, M Giliberto, L Karlsen, P Ayuda-Durán, R Rosenquist, ... Application of drug sensitivity screening in B-cell malignancies for …, 2022 | | 2022 |
| A cell competition-based drug screen identifies a novel compound that induces dual c-Myc depletion and p53 activation DS Tadele, J Robertson, R Crispin, MC Herrera, M Chlubnova, ... | | 2020 |
| A cell competition-based drug screen identifies a novel compound that induces dual c-Myc degradation and p53 activation DS Tadele, J Robertson, R Crispin, MC Herrera, M Chlubnova, ... bioRxiv, 2020.05. 16.089755, 2020 | | 2020 |
| Interferon Alpha and Kinase Inhibitor Nilotinib Increase Cell Adhesion and Tunneling Nanotubes in CML M Omsland, V Andresen, P Ayuda-Durán, S Gullaksen, R Hovland, ... | | 2018 |
Jorrit EnserinkGroup leader at Oslo University Hospital在 rr-research.no 的电子邮件经过验证
